These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2318449

  • 1. Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity.
    Nam JH, Cole LA, Chambers JT, Schwartz PE.
    Gynecol Oncol; 1990 Mar; 36(3):383-90. PubMed ID: 2318449
    [Abstract] [Full Text] [Related]

  • 2. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA, Wang YX, Elliott M, Latif M, Chambers JT, Chambers SK, Schwartz PE.
    Cancer Res; 1988 Mar 01; 48(5):1356-60. PubMed ID: 3342414
    [Abstract] [Full Text] [Related]

  • 3. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers.
    Cole LA, Schwartz PE, Wang YX.
    Gynecol Oncol; 1988 Sep 01; 31(1):82-90. PubMed ID: 3044936
    [Abstract] [Full Text] [Related]

  • 4. Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic mass.
    Cole LA, Nam JH, Chambers JT, Schwartz PE.
    Gynecol Oncol; 1990 Mar 01; 36(3):391-4. PubMed ID: 2318450
    [Abstract] [Full Text] [Related]

  • 5. Urinary gonadotropin fragment (UGF) measurements in the diagnosis and management of ovarian cancer.
    Cole LA, Nam JH.
    Yale J Biol Med; 1989 Mar 01; 62(4):367-78. PubMed ID: 2596125
    [Abstract] [Full Text] [Related]

  • 6. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
    Neven P, Iles RK, Lee CL, Hudson CN, Shepherd JH, Chard T.
    Cancer; 1993 Jun 15; 71(12):4124-30. PubMed ID: 7685240
    [Abstract] [Full Text] [Related]

  • 7. Improved methods for detecting beta-core in normal and cancer patient urines.
    Tanaka A, Cole LA.
    Clin Chem; 1994 Dec 15; 40(12):2317-8. PubMed ID: 7988019
    [No Abstract] [Full Text] [Related]

  • 8. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
    Cole LA, Tanaka A, Kim GS, Park SY, Koh MW, Schwartz PE, Chambers JT, Nam JH.
    Gynecol Oncol; 1996 Feb 15; 60(2):264-70. PubMed ID: 8631549
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. UGP--a tumor marker of gynecologic and breast malignancies? Specificity and sensitivity in pretherapeutic patients and the influence of hormonal substitution on the expression of UGP.
    Schwarz-Roeger U, Petzoldt B, Waldschmidt R, Walker RP, Bauknecht T, Kiechle M.
    Anticancer Res; 1997 Feb 15; 17(4B):3041-5. PubMed ID: 9329597
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
    Nishimura R, Kobayashi K, Katsuno M, Kobayashi T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb 15; 42(2):143-8. PubMed ID: 1690253
    [Abstract] [Full Text] [Related]

  • 13. Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies.
    Walker R, Crebbin V, Stern J, Scudder S, Schwartz P.
    Anticancer Res; 1994 Feb 15; 14(5A):1703-9. PubMed ID: 7847804
    [Abstract] [Full Text] [Related]

  • 14. Urinary gonadotropin fragment, a new tumor marker. III. Use in cervical and vulvar cancers.
    Nam JH, Chang KC, Chambers JT, Schwartz PE, Cole LA.
    Gynecol Oncol; 1990 Jul 15; 38(1):66-70. PubMed ID: 2354828
    [Abstract] [Full Text] [Related]

  • 15. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. II. Initial serial studies.
    Wang YX, Schwartz PE, Chambers JT, Cole LA.
    Gynecol Oncol; 1988 Sep 15; 31(1):91-102. PubMed ID: 3410359
    [Abstract] [Full Text] [Related]

  • 16. Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
    Schutter EM, Mijatovic V, Kok A, Van Kamp GJ, Verstraeten R, Verheijen RH.
    Anticancer Res; 1999 Sep 15; 19(6C):5551-7. PubMed ID: 10697615
    [Abstract] [Full Text] [Related]

  • 17. The measurement of urinary beta core fragment in conjunction with serum CA125 does not aid the differentiation of malignant from benign pelvic masses.
    Carter PG, Iles RK, Neven P, Davies AP, Shepherd JH, Chard T.
    Gynecol Oncol; 1993 Dec 15; 51(3):368-71. PubMed ID: 8112647
    [Abstract] [Full Text] [Related]

  • 18. Urinary gonadotropin fragment, a new tumor marker. IV. Use in endometrial cancers and uterine mixed mullerian tumors.
    Nam JH, Chambers JT, Schwartz PE, Cole LA.
    Gynecol Oncol; 1990 Dec 15; 39(3):352-7. PubMed ID: 2175287
    [Abstract] [Full Text] [Related]

  • 19. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
    Yoshimura M, Nishimura R, Murotani A, Miyamoto Y, Nakagawa T, Hasegawa K, Koizumi T, Shii K, Baba S, Tsubota N.
    Cancer; 1994 Jun 01; 73(11):2745-52. PubMed ID: 7514953
    [Abstract] [Full Text] [Related]

  • 20. Diurnal variation of urinary "hCG beta subunit core fragment" production evaluated in patients with gynecological neoplasms.
    Neven P, Iles RK, Carter PG, Shepherd JH, Chard T.
    Clin Chem; 1994 Mar 01; 40(3):484-5. PubMed ID: 7510595
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.